Science Explorer Back to mapMap
Discussion
Company · Durham · United States

Chimerix (United States)

chimerix.comROR OpenAlex
Research works
83
▲ 64% vs 2018-21
Citations
1.8k
22.1 per fractional work
Top-10% rate
12.2%
all institutions 10.0%
Open access
62%
world 40%
International
18%
world 18%
Chimerix (United States)

Not ranked overall: Chimerix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Chimerix (United States) work in?

In 2022-now, 51% of research at Chimerix (United States) is in Life Sciences, 45% in Health Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (43%), Immunology and Microbiology (5%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 11 fractional works · 50.8% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 42.9% of its workMolecular Biology: 4 fractional works · 17.6% of its workCancer Research: 3 fractional works · 15.6% of its workGenetics: 1 fractional works · 3.8% of its workCell Biology: 1 fractional works · 2.5% of its workBiotechnology: 0 fractional works · 1.8% of its workBiochemistry: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.4% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 5.1% of its workVirology: 1 fractional works · 2.8% of its workImmunology: 0 fractional works · 1.5% of its workMicrobiology: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.4% of its workPharmacology: 1 fractional works · 2.4% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workHealth Sciences: 9 fractional works · 45.4% of its workMedicine: 9 fractional works · 44.9% of its workOncology: 3 fractional works · 13.2% of its workGenetics: 2 fractional works · 9.9% of its workPsychiatry and Mental health: 1 fractional works · 4.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.0% of its workRheumatology: 0 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.9% of its workNeurology: 0 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workInfectious Diseases: 0 fractional works · 0.8% of its workOphthalmology: 0 fractional works · 0.8% of its workGeriatrics and Gerontology: 0 fractional works · 0.7% of its workReproductive Medicine: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 3.8% of its workEngineering: 0 fractional works · 1.6% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workMaterials Science: 0 fractional works · 1.6% of its workBiomaterials: 0 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.3% of its workPollution: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.0% of its workALL ITS WORKChimerix (UnitedStates)21fractional works, 2022-now
Life Sciences51%Physical Sciences4%Health Sciences45%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology942.9%
    2. Immunology and Microbiology15.1%
    3. Pharmacology, Toxicology and Pharmaceutics12.4%
    4. Neuroscience00.3%
    1. Medicine944.9%
    2. Dentistry00.3%
    3. Veterinary00.2%
    1. Engineering01.6%
    2. Materials Science01.6%
    3. Environmental Science00.6%
    4. Mathematics00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.04× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 5.07× its world share, 1 worksImmunology and Micro…Neuroscience: 0.21× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.94× its world share, 0 worksPharmacology, Toxico…Engineering: 0.11× its world share, 0 worksEngineeringEnvironmental Science: 0.13× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.46× its world share, 0 worksMaterials ScienceMathematics: 0.05× its world share, 0 worksMathematicsDentistry: 0.55× its world share, 0 worksDentistryMedicine: 2.34× its world share, 9 worksMedicineVeterinary: 1.30× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.0×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.04×9 works
  2. Pharmacology, Toxicology and Pharmaceutics6.94×0 works
  3. Immunology and Microbiology5.07×1 works
  4. Medicine2.34×9 works
  5. Veterinary1.30×0 works
  6. Dentistry0.55×0 works
  7. Materials Science0.46×0 works
  8. Neuroscience0.21×0 works
  9. Environmental Science0.13×0 works
  10. Engineering0.11×0 works
  11. Mathematics0.05×0 works

Who are the top researchers at Chimerix (United States)?

Ranked on the quality score, Scott A. Foster, Wendy Painter and Garrett Nichols lead among researchers whose main affiliation is Chimerix (United States).

  1. 1 Scott A. Foster United States · #289,600 worldwide 6.9k citations · 98 works
  2. 2 Wendy Painter United States · #404,598 worldwide 2.3k citations · 38 works
  3. 3 Garrett Nichols United States · #721,124 worldwide 3k citations · 43 works
  4. 4 Lawrence C. Trost United States · #922,798 worldwide 3.1k citations · 35 works
  5. 5 Samuel Ramage United States · #1,011,494 worldwide 387 citations · 121 works
  6. 6 Marion E. Morrison United States · #1,081,465 worldwide 760 citations · 23 works
  7. 7 Alice T. Robertson United States · #1,319,649 worldwide 1.6k citations · 41 works
  8. 8 Herve Momméja-Marin United States · #1,340,074 worldwide 1.7k citations · 41 works
  9. 9 Thomas M. Brundage United States · #1,568,399 worldwide 1.1k citations · 32 works
  10. 10 Randall Lanier United States · #1,931,394 worldwide 1.5k citations · 42 works
All ranked researchers at Chimerix (United States)

What are the most cited papers from Chimerix (United States)?

The most cited paper from Chimerix (United States) is "Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1." (Per T Ljungman, Michael Boeckh, Hans Hellmuth Hirsch et al., 2016), with 966 citations. Next come "CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation" (374) and "Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial" (298).

Most cited papers
#PaperReleasedCitations
1 Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1. Per T Ljungman, Michael Boeckh, Hans Hellmuth Hirsch et al. · Clinical Infectious Diseases 28 Sep 2016 966
2 CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation Francisco M. Marty, Drew J. Winston, Scott D. Rowley et al. · New England Journal of Medicine Open access 25 Sep 2013 374
3 Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial Kris V. Kowdley, Eric Lawitz, Israel Crespo et al. · The Lancet 15 Mar 2013 298
4 Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection Thomas H. Price, Michael Boeckh, Ryan W. Harrison et al. · Blood Open access 2 Sep 2015 254
5 A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation Francisco M. Marty, Drew J. Winston, Roy F. Chemaly et al. · Transplantation and Cellular Therapy Open access 4 Oct 2018 220
All 60 most cited papers, with filters and sorting

Which keywords describe research at Chimerix (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, HIF-1, Warburg Effect, Molecular Classification, Glioblastoma, Temozolomide and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Immunotherapy5▲ 32×9 topics
  2. Tumor Microenvironment3▲ 34×3 topics
  3. HIF-13▲ 220×1 topic
  4. Warburg Effect3▲ 220×1 topic
  5. Glioblastoma2▲ 144×1 topic
  6. Molecular Classification2▲ 66×2 topics
  7. Temozolomide2▲ 144×1 topic
  8. Cancer Therapy2▲ 13×7 topics
  9. Tumor Regression2▲ 66×2 topics
  10. Cell Death2▲ 30×5 topics
  11. Oxidative Stress2▲ 4.3×7 topics
  12. Reactive Oxygen Species1▲ 15×3 topics
  13. CAR T Cells1▲ 77×1 topic
  14. Chimeric Antigen Receptor1▲ 77×1 topic
  15. Metabolic Regulation1▲ 34×2 topics
  16. Mitochondria1▲ 40×3 topics
  17. Gene Therapy1▲ 25×2 topics
  18. Tumor Targeting1▲ 27×3 topics

Which research topics does Chimerix (United States) publish most on?

By volume in 2022-now: Cancer, Hypoxia, and Metabolism, Glioma Diagnosis and Treatment, CAR-T cell therapy research and Mitochondrial Function and Pathology.

Cancer, Hypoxia, and Met…3Cancer, Hypoxia, and Metabolism: 3 fractional worksGlioma Diagnosis and Tre…2Glioma Diagnosis and Treatment: 2 fractional worksCAR-T cell therapy research: 1 fractional worksMitochondrial Function and Pathology: 1 fractional worksCancer, Stress, Anesthesia, and Immune Response: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksVirus-based gene therapy research: 1 fractional worksCancer therapeutics and mechanisms: 1 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional works
Cancer ResearchGeneticsOncologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer, Hypoxia, and Metabolism Cancer Research 3 works
  2. 2 Glioma Diagnosis and Treatment Genetics 2 works
  3. 3 CAR-T cell therapy research Oncology 1 works
  4. 4 Mitochondrial Function and Pathology Molecular Biology 1 works
  5. 5 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 1 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  7. 7 Virus-based gene therapy research Genetics 1 works
  8. 8 Cancer therapeutics and mechanisms Molecular Biology 1 works
  9. 9 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  10. 10 Peptidase Inhibition and Analysis Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.2%not open37.8%

World: 40% of research is openly available.

with international co-authors18.0%domestic only82.0%

World: 18% is written across borders.

How has Chimerix (United States)'s research output changed?

Output in 2022-2025 was 64% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Chimerix (United States) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00010%0.00020%0.00030%Chimerix (United States)0.00013% in 202519801990200020102020

Fractional works of Chimerix (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Chimerix (United States). Posts are plain text and can be reported.